111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.

111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.

OBJECTIVE: Probing intranuclear proteins in breast cancer (BC) cells by using radiolabeled antibodies is restricted by delivery barriers presented by cell and nuclear membranes. Our aim was to construct immunoconjugates (ICs) bispecific for epidermal growth factor receptors (EGFRs) and the intranuc...

Full description

Bibliographic Details
Main Authors:	Cornelissen, B, Kersemans, V, McLarty, K, Tran, L, Reilly, R
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Biodistribution and nuclear import of 111In-labeled HIV-1 tat peptide immunoconjugates after intravenous or intratumoural injection in tumour-bearing mice
by: Cornelissen, B, et al.
Published: (2006)

Kinetics of internalization and nuclear import and efflux of 111In-and 123I-labeled HIV-1 tat-peptide immunoconjugates (IC's) in BT-474 human breast cancer cells
by: Cornelissen, B, et al.
Published: (2006)

Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells.
by: Cornelissen, B, et al.
Published: (2007)

In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.
by: Cornelissen, B, et al.
Published: (2009)

Properties of [(111)In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection.
by: Cornelissen, B, et al.
Published: (2008)

The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin).
by: Cornelissen, B, et al.
Published: (2008)

Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01)

PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.
by: Knight, J, et al.
Published: (2015)

PET imaging of DNA damage using 89Zr-labelled anti-γH2AX-TAT immunoconjugates
by: Knight, J, et al.
Published: (2015)

Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo.
by: Zhang, W, et al.
Published: (2005)

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
by: McLarty, K, et al.
Published: (2009)

Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.
by: Cornelissen, B, et al.
Published: (2011)

Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.
by: Ellis, M, et al.
Published: (1999)

Cyclin E and p27/Kip1: two proteins on a see-saw or another false dawn?
by: Chetty, R
Published: (2002)

Immunohistochemical Expression of p27<sup>Kip1</sup>, p57<sup>Kip2</sup>, Cyclin D1, Nestin, and Ki-67 in Ependymoma
by: Shahad Iqneibi, et al.
Published: (2022-02-01)

Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
by: McLarty, K, et al.
Published: (2009)

Auger electron therapy using In-111-labelled F3 peptide
by: Cornelissen, B, et al.
Published: (2011)

Indium-111 labeled anti-CD33 monoclonal antibodies (mAbs) modified with nuclear-localizing sequences (NLS) kill mitoxantrone-resistant HL-60 acute myelogenous leukemia (AML) cells
by: Kersemans, V, et al.
Published: (2006)

Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate.
by: Costantini, D, et al.
Published: (2008)

ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
by: Cornelissen, B, et al.
Published: (2011)

Cip/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy
by: DePamphilis Melvin L, et al.
Published: (2009-06-01)

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.
by: Fredersdorf, S, et al.
Published: (1997)

Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
by: Gillett, C, et al.
Published: (1999)

Accelerated turnover of taste bud cells in mice deficient for the cyclin-dependent kinase inhibitor p27<sup>Kip1</sup>
by: Perna Marla K, et al.
Published: (2011-04-01)

Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenografts.
by: Costantini, D, et al.
Published: (2010)

In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR
by: Reilly, R, et al.
Published: (2000)

111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
by: Reilly, R, et al.
Published: (2000)

Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenation.
by: Christian Wulbrand, et al.
Published: (2013-01-01)

Cryo-EM structure of SKP1-SKP2-CKS1 in complex with CDK2-cyclin A-p27KIP1
by: Rhianna J. Rowland, et al.
Published: (2023-07-01)

A phase I trial of In-111-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer
by: Vallis, K, et al.
Published: (2008)

Targeted Therapy With Immunoconjugates for Multiple Myeloma
by: Wassilis S. C. Bruins, et al.
Published: (2020-06-01)

Expression of cyclooxygenase-2(COX-2) and cyclin dependent kinase 1B (CDKN1B/p27Kip1⁯) in human prostatet adenocarcinoma
by: Md Roduan, Mohd Rohaizad
Published: (2011)

Regulation of p27<sup>Kip1</sup> and p57<sup>Kip2</sup> Functions by Natural Polyphenols
by: Gian Luigi Russo, et al.
Published: (2020-09-01)

A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications.
by: Reilly, R, et al.
Published: (2004)

Screening For Small Molecule Inhibitors Of p27Kip1 Degradation
by: Ooi, Li Ching
Published: (2012)

p27KIP1 Deletions in Childhood Acute Lymphoblastic Leukemia
by: Hiroaki Komuro, et al.
Published: (1999-08-01)

Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway
by: Mengling Liu, et al.
Published: (2022-09-01)

Down-Regulation of CK2α Leads to Up-Regulation of the Cyclin-Dependent Kinase Inhibitor p27KIP1 in Conditions Unfavorable for the Growth of Myoblast Cells
by: Barbara Guerra, et al.
Published: (2020-11-01)

Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.
by: Vallis, K, et al.
Published: (2014)

Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences.
by: Kersemans, V, et al.
Published: (2008)